VALMID Drug Patent Profile
✉ Email this page to a colleague
When do Valmid patents expire, and when can generic versions of Valmid launch?
Valmid is a drug marketed by Dista and is included in one NDA.
The generic ingredient in VALMID is ethinamate. There is one drug master file entry for this compound. Additional details are available on the ethinamate profile page.
Summary for VALMID
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 21 |
Patent Applications: | 1,033 |
Formulation / Manufacturing: | see details |
DailyMed Link: | VALMID at DailyMed |
US Patents and Regulatory Information for VALMID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dista | VALMID | ethinamate | CAPSULE;ORAL | 009750-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |